Nektar Therapeutics SG&A Expense (Annual) Insights

Nektar Therapeutics (NKTR)

1.17 +0.06 (+5.41%) USD | NASDAQ | Sep 27, 16:00

1.175 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1994. Upgrade now.

Date	Value
December 31, 2023	77.42M
December 31, 2022	92.33M
December 31, 2021	122.84M
December 31, 2020	104.68M
December 31, 2019	98.71M
December 31, 2018	81.44M
December 31, 2017	52.36M
December 31, 2016	44.28M
December 31, 2015	43.27M
December 31, 2014	40.92M
December 31, 2013	40.53M
December 31, 2012	41.61M
December 31, 2011	46.76M
December 31, 2010	40.99M
December 31, 2009	41.01M

Date	Value
December 31, 2008	51.50M
December 31, 2007	57.28M
December 31, 2006	82.36M
December 31, 2005	43.85M
December 31, 2004	30.97M
December 31, 2003	22.02M
December 31, 2002	26.02M
December 31, 2001	18.86M
December 31, 2000	13.93M
December 31, 1999	7.869M
December 31, 1998	8.387M
December 31, 1997	6.328M
December 31, 1996	4.00M
December 31, 1995	3.20M
December 31, 1994	7.40M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

77.42M

Minimum

2023

122.84M

Maximum

2021

99.20M

Average

98.71M

Median

2019

SG&A Expense (Annual) Benchmarks